Recently, Geneva has disclosed the complete DNA sequences of two monkeypox viruses first discovered in Switzerland on May 21 and 24, 2022 It is reported that the Geneva Center for emerging viral diseases shared the first sequencing results of the monkeypox genome in Switzerland. This important step will enable people to further analyze and compare genome sequences with those of other countries.
According to the preliminary results, the virus sequences of the first two cases in Switzerland are genomically related to the cases reported by several other countries. The national emerging virus reference laboratory (crive) team of the country shares its genome with the scientific community through the platform gene bank.
In Switzerland, the virology laboratory of Geneva University Hospital (hub) has confirmed four monkeypox cases through PCR testing. The laboratory is part of critical and is authorized by the Swiss Federal Office of public health (foph) to monitor such events. According to the WHO report, since the first case was reported in the UK on 7 may 2022, these cases are part of a larger and unusual epidemic that has continued to break out in many countries in Europe, South America, North America and Australia, with more than 400 confirmed cases.
The virus can be identified by PCR, especially from affected lesions and other samples. To date, diagnostics have been based on tests developed by specialized laboratories, such as those in Geneva. In order to enable other laboratories in Switzerland and around the world to include this test in their orthopoxvirus test portfolio, crystal is sharing its agreement.
At present, crystal is paying close attention to this situation and can meet all diagnostic requirements related to this epidemic.